Biotech

All Articles

Lykos 'remorses' certainly not revealing research study transgressions with author

.Psychopharmacology has actually pulled three write-ups concerning midstage clinical trial data dete...

Analysts dig into Avidity's DMD succeed, showing nuances in data

.Avidity Biosciences satisfied clients along with stage 1/2 records in Duchenne muscle dystrophy (DM...

Actinogen's cortisol blocker fails phase 2 depression research study

.Actinogen Medical's cortisol blocker has actually missed out on the primary endpoint of a stage 2 r...

Bivictrix determines going personal only method to take ADC right into center

.Antibody-drug conjugates (ADCs) have gone to the facility of many a billion-dollar biobuck licensin...

TPG tops up funds to $580M for expenditures throughout lifestyle sciences

.Property supervisor TPG, which has actually assisted biotechs including Sionna Therapeutics as well...

Merck ceases period 3 TIGIT test in bronchi cancer for futility

.Merck &amp Co.'s TIGIT course has endured another problem. Months after shuttering a stage 3 cancer...

After a hard year, Exscientia folds up into Recursion

.After a year specified by pipeline cuts, the shift of its own chief executive officer and cutbacks,...

Cullinan, after $25M deal, return bispecific to Port

.Cullinan Therapeutics was thrilled enough with Port BioMed's bispecific invulnerable reactor that i...

A nearer consider Strong Biotech's Ferocious 15

.In this particular week's incident of "The Leading Pipe," we're diving in to Strong Biotech's yearl...

Lilly faces phase 2 failure of tau-targeting med

.The confetti is actually still soaring coming from Eli Lilly's party celebrating the approval of Al...